Brzezinka, K.; Nevedomskaya, E.; Lesche, R.; Haegebarth, A.; ter Laak, A.; Fernández-Montalván, A.E.; Eberspaecher, U.; Werbeck, N.D.; Moenning, U.; Siegel, S.;
et al. Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target. Cancers 2020, 12, 201.
https://doi.org/10.3390/cancers12010201
AMA Style
Brzezinka K, Nevedomskaya E, Lesche R, Haegebarth A, ter Laak A, Fernández-Montalván AE, Eberspaecher U, Werbeck ND, Moenning U, Siegel S,
et al. Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target. Cancers. 2020; 12(1):201.
https://doi.org/10.3390/cancers12010201
Chicago/Turabian Style
Brzezinka, Krzysztof, Ekaterina Nevedomskaya, Ralf Lesche, Andrea Haegebarth, Antonius ter Laak, Amaury E. Fernández-Montalván, Uwe Eberspaecher, Nicolas D. Werbeck, Ursula Moenning, Stephan Siegel,
and et al. 2020. "Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target" Cancers 12, no. 1: 201.
https://doi.org/10.3390/cancers12010201
APA Style
Brzezinka, K., Nevedomskaya, E., Lesche, R., Haegebarth, A., ter Laak, A., Fernández-Montalván, A. E., Eberspaecher, U., Werbeck, N. D., Moenning, U., Siegel, S., Haendler, B., Eheim, A. L., & Stresemann, C.
(2020). Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target. Cancers, 12(1), 201.
https://doi.org/10.3390/cancers12010201